Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosis-Reference-Cited by-同舟云学术

Prescription rates for drugs used in treatment of benign prostatic hyperplasia and erectile dysfunction before and after prostate cancer diagnosis

Published:2022-06-06 Issue:8 Volume:61 Page:931-938
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Duun-Henriksen Anne Katrine¹^ORCID,Dehlendorff Christian¹^ORCID,Røder Martin Andreas²³^ORCID,Skriver Charlotte⁴^ORCID,Pottegård Anton⁵^ORCID,Friis Søren⁴,Brasso Klaus²³^ORCID,Larsen Signe Benzon²⁶^ORCID

Affiliation:

1. Statistics and Data Analysis, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

2. Department of Urology, Urological Research Unit, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark

3. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

4. Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

5. Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark

6. Survivorship and Inequality in Cancer, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

Funder

Peer Kølendorf Family Foundation

Danish Cancer Society Scientific Committee

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2082886

Reference30 articles.

1. Erectile Dysfunction and Lower Urinary Tract Symptoms

2. Benign prostatic hyperplasia – what do we know?

3. Larønningen S, Ferlay J, Bray F, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 9.1. Nord Cancer Incid Mortality, Preval Surviv Nord Countries, Version 91. 2021.

4. Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975–2013

5. Management of Benign Prostatic Hyperplasia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of lag times in cancer pharmacoepidemiology: a narrative review;Annals of Epidemiology;2023-08

2. Talking about sex: erectile dysfunction in the oncology patient;Endocrine-Related Cancer;2023-03-27

3. Chikusetsu saponin IVA induces apoptosis and mitochondrial dysfunction of benign prostatic hyperplasia epithelial cell line (BPH-1) by inhibiting JAK/STAT3 signaling pathway;Tropical Journal of Pharmaceutical Research;2023-02-13